BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34214250)

  • 1. PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma-initiating cell properties via DNA methyltransferase 3A.
    Tanabe R; Miyazono K; Todo T; Saito N; Iwata C; Komuro A; Sakai S; Raja E; Koinuma D; Morikawa M; Westermark B; Heldin CH
    Mol Oncol; 2022 Jan; 16(1):269-288. PubMed ID: 34214250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
    Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
    J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation.
    Tao Z; Li T; Ma H; Yang Y; Zhang C; Hai L; Liu P; Yuan F; Li J; Yi L; Tong L; Wang Y; Xie Y; Ming H; Yu S; Yang X
    Cell Death Dis; 2018 Oct; 9(11):1063. PubMed ID: 30337536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
    Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
    Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV.
    Niibori-Nambu A; Midorikawa U; Mizuguchi S; Hide T; Nagai M; Komohara Y; Nagayama M; Hirayama M; Kobayashi D; Tsubota N; Takezaki T; Makino K; Nakamura H; Takeya M; Kuratsu J; Araki N
    PLoS One; 2013; 8(5):e59558. PubMed ID: 23704872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prrx1 promotes stemness and angiogenesis via activating TGF-β/smad pathway and upregulating proangiogenic factors in glioma.
    Chen Z; Chen Y; Li Y; Lian W; Zheng K; Zhang Y; Zhang Y; Lin C; Liu C; Sun F; Sun X; Wang J; Zhao L; Ke Y
    Cell Death Dis; 2021 Jun; 12(6):615. PubMed ID: 34131109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors.
    Ikushima H; Todo T; Ino Y; Takahashi M; Miyazawa K; Miyazono K
    Cell Stem Cell; 2009 Nov; 5(5):504-14. PubMed ID: 19896441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snail depletes the tumorigenic potential of glioblastoma.
    Savary K; Caglayan D; Caja L; Tzavlaki K; Bin Nayeem S; Bergström T; Jiang Y; Uhrbom L; Forsberg-Nilsson K; Westermark B; Heldin CH; Ferletta M; Moustakas A
    Oncogene; 2013 Nov; 32(47):5409-20. PubMed ID: 23524585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
    Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
    Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
    Raja E; Komuro A; Tanabe R; Sakai S; Ino Y; Saito N; Todo T; Morikawa M; Aburatani H; Koinuma D; Iwata C; Miyazono K
    Oncogene; 2017 Aug; 36(35):4963-4974. PubMed ID: 28459464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.
    Raja E; Morikawa M; Nishida J; Tanabe R; Takahashi K; Seeherman HJ; Saito N; Todo T; Miyazono K
    Cancer Sci; 2019 Nov; 110(11):3486-3496. PubMed ID: 31483918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective calcium sensitivity in immature glioma cancer stem cells.
    Wee S; Niklasson M; Marinescu VD; Segerman A; Schmidt L; Hermansson A; Dirks P; Forsberg-Nilsson K; Westermark B; Uhrbom L; Linnarsson S; Nelander S; Andäng M
    PLoS One; 2014; 9(12):e115698. PubMed ID: 25531110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation.
    Gopisetty G; Xu J; Sampath D; Colman H; Puduvalli VK
    Oncogene; 2013 Jun; 32(26):3119-29. PubMed ID: 22945648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.
    Cheng RB; Ma RJ; Wang ZK; Yang SJ; Lin XZ; Rong H; Ma Y
    Mol Cell Biochem; 2011 Mar; 349(1-2):149-57. PubMed ID: 21110069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snail regulates BMP and TGFβ pathways to control the differentiation status of glioma-initiating cells.
    Caja L; Tzavlaki K; Dadras MS; Tan EJ; Hatem G; Maturi NP; Morén A; Wik L; Watanabe Y; Savary K; Kamali-Moghaddan M; Uhrbom L; Heldin CH; Moustakas A
    Oncogene; 2018 May; 37(19):2515-2531. PubMed ID: 29449696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma formation from cell population depleted of Prominin1-expressing cells.
    Nishide K; Nakatani Y; Kiyonari H; Kondo T
    PLoS One; 2009 Aug; 4(8):e6869. PubMed ID: 19718438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMPs as therapeutic targets and biomarkers in astrocytic glioma.
    González-Gómez P; Anselmo NP; Mira H
    Biomed Res Int; 2014; 2014():549742. PubMed ID: 24877113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways.
    Wang H; Sun T; Hu J; Zhang R; Rao Y; Wang S; Chen R; McLendon RE; Friedman AH; Keir ST; Bigner DD; Li QJ; Wang H; Wang XF
    J Clin Invest; 2014 Oct; 124(10):4489-502. PubMed ID: 25202981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.